Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunologic kidney disease.

G H Bock, R L Vernier

    American Family Physician
    |November 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    This study reviews immunologically mediated renal diseases like Goodpasture's syndrome and lupus nephritis. While treatments show promise for lupus nephritis, outcomes for other immune-related kidney diseases remain uncertain.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Studies on chronic membranoproliferative glomerulonephritis with hypocomplementemia.

    The Journal of experimental medicine·2009
    Same author

    Improved growth velocity with intensive dialysis. Consequence or coincidence?

    Pediatric nephrology (Berlin, Germany)·2000
    Same author

    Cytomegalovirus infections following renal transplantation--effects on antiviral prophylaxis: a report of the North American Pediatric Renal Transplant Cooperative Study.

    Pediatric nephrology (Berlin, Germany)·1998
    Same author

    Circulating erythropoietin and interleukin-6 concentrations increase in critically ill children with sepsis and septic shock.

    Critical care medicine·1996
    Same author

    Glomerulonephritis in children with Down syndrome.

    Pediatric nephrology (Berlin, Germany)·1996
    Same author

    Current status of pediatric home peritoneal dialysis training in the United States.

    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·1995
    Same journal

    For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

    American family physician·2026
    Same journal

    Nausea and Vomiting During Pregnancy.

    American family physician·2026
    Same journal

    Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

    American family physician·2026
    Same journal

    Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

    American family physician·2026
    Same journal

    Overscreening Leads to Overdiagnosis of MASLD.

    American family physician·2026
    Same journal

    Type 2 Diabetes: Outpatient Insulin Management.

    American family physician·2026
    See all related articles

    Area of Science:

    • Nephrology
    • Immunology
    • Internal Medicine

    Background:

    • Immunologically mediated renal diseases encompass a range of conditions affecting the kidneys.
    • Key examples include Goodpasture's syndrome, systemic lupus erythematosus, and IgA nephropathy.

    Purpose of the Study:

    • To outline the spectrum of immunologically mediated renal diseases.
    • To differentiate the underlying pathogenic mechanisms.
    • To discuss current treatment strategies and their efficacy.

    Main Methods:

    • Review of established literature on immune-mediated kidney diseases.
    • Classification based on pathogenic mechanisms (autoantibodies vs. immune complex deposition).
    • Summary of therapeutic approaches and reported outcomes.

    Related Experiment Videos

    Main Results:

    • Goodpasture's syndrome involves antibodies targeting the glomerular basement membrane.
    • Other conditions result from immune complex deposition in glomeruli.
    • Steroids and immunosuppressives are effective for lupus nephritis, with variable results for other diseases.

    Conclusions:

    • Understanding the distinct immunopathogenesis is crucial for targeted treatment.
    • Efficacy of immunosuppressive therapy varies across different immune-mediated renal diseases.
    • Further research is needed to optimize treatment for less responsive conditions.